TY - JOUR
T1 - Outcomes for Pressure Ulcer Trials (OUTPUTs)
T2 - protocol for the development of a core domain set for trials evaluating the clinical efficacy or effectiveness of pressure ulcer prevention interventions
AU - Lechner, Anna
AU - Kottner, Jan
AU - Coleman, Susanne
AU - Muir, Delia
AU - Bagley, Heather
AU - Beeckman, Dimitri
AU - Chaboyer, Wendy
AU - Cuddigan, Janet
AU - Moore, Zena
AU - Rutherford, Claudia
AU - Schmitt, Jochen
AU - Nixon, Jane
AU - Balzer, Katrin
PY - 2019/7/22
Y1 - 2019/7/22
N2 - © 2019 The Author(s). Background: Core outcome sets (COS) are being developed in many clinical areas to increase the quality and comparability of clinical trial results as well as to ensure their relevance for patients. A COS represents an agreed standardized set of outcomes that describes the minimum that should be consistently reported in all clinical trials of a defined area. It comprises a core domain set (defining what core outcomes should be measured) and a core measurement set (defining measurement/assessment instruments for each core domain). For pressure ulcer prevention trials a COS is lacking. The great heterogeneity of reported outcomes in this field indicates the need for a COS. Methods/design: The first part of this project aims to develop a core domain set by following established methods, which incorporates four steps: (1) definition of the scope, (2) conducting a scoping review, (3) organizing facilitated workshops with service users, (4) performing Delphi surveys and establishing consensus in a face-to-face meeting with different stakeholders. Discussion: After achieving consensus on the core domain set, further work will be undertaken to determine a corresponding core measurement set. This will lead to better pressure ulcer prevention research in the future. There are a number of methodological challenges in the field of COS development. To meet these challenges and to ensure a high-quality COS, the OUTPUTS project affiliates to current standards and works in close collaboration with international experts and with existing international service user groups.
AB - © 2019 The Author(s). Background: Core outcome sets (COS) are being developed in many clinical areas to increase the quality and comparability of clinical trial results as well as to ensure their relevance for patients. A COS represents an agreed standardized set of outcomes that describes the minimum that should be consistently reported in all clinical trials of a defined area. It comprises a core domain set (defining what core outcomes should be measured) and a core measurement set (defining measurement/assessment instruments for each core domain). For pressure ulcer prevention trials a COS is lacking. The great heterogeneity of reported outcomes in this field indicates the need for a COS. Methods/design: The first part of this project aims to develop a core domain set by following established methods, which incorporates four steps: (1) definition of the scope, (2) conducting a scoping review, (3) organizing facilitated workshops with service users, (4) performing Delphi surveys and establishing consensus in a face-to-face meeting with different stakeholders. Discussion: After achieving consensus on the core domain set, further work will be undertaken to determine a corresponding core measurement set. This will lead to better pressure ulcer prevention research in the future. There are a number of methodological challenges in the field of COS development. To meet these challenges and to ensure a high-quality COS, the OUTPUTS project affiliates to current standards and works in close collaboration with international experts and with existing international service user groups.
UR - http://www.scopus.com/inward/record.url?scp=85069790919&partnerID=8YFLogxK
UR - http://www.mendeley.com/research/outcomes-pressure-ulcer-trials-outputs-protocol-development-core-domain-set-trials-evaluating-clinic
U2 - 10.1186/s13063-019-3543-9
DO - 10.1186/s13063-019-3543-9
M3 - Journal articles
C2 - 31331366
VL - 20
SP - 449
JO - Trials
JF - Trials
IS - 1
M1 - 449
ER -